Palisade Bio (PALI) Total Non-Current Liabilities (2012 - 2026)

Palisade Bio (PALI) has reported Total Non-Current Liabilities for 15 consecutive years, with $5.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Total Non-Current Liabilities rose 98.88% year-over-year to $5.7 million; the TTM figure through Mar 2026 stood at $5.7 million (up 98.88% YoY), while the FY2025 annual figure was $4.7 million, up 45.09% from the prior year.
• Total Non-Current Liabilities improved to $5.7 million in Q1 2026 per PALI's latest filing, from $4.7 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $5.7 million in Q1 2026 and bottomed at $1.5 million in Q1 2023.
• Historically, Total Non-Current Liabilities has averaged $3.2 million across 5 years, with a median of $2.9 million in 2024.
• Annual changes were most pronounced in 2023 — Total Non-Current Liabilities dropped 26.09% — and 2026, when it surged 98.88%.
• Palisade Bio's Total Non-Current Liabilities stood at $3.3 million in 2022, then declined by 16.66% to $2.7 million in 2023, then rose by 18.3% to $3.2 million in 2024, then soared by 45.09% to $4.7 million in 2025, then rose by 20.95% to $5.7 million in 2026.
• Business Quant data shows PALI's Total Non-Current Liabilities at $5.7 million in Q1 2026, $4.7 million in Q4 2025, and $3.8 million in Q3 2025.